Key result
Antithrombotic agents for patients with heart failure or reduced ventricular function lack definitive prospective studies to conclusively demonstrate their efficacy.
Why the study?
Do antithrombotic agents provide clinical benefit in patients with heart failure or reduced ventricular function?
Do antithrombotic agents provide clinical benefit in patients with heart failure or reduced ventricular function?
No takes yet. Share an insight, caveat, or question.
The use of antithrombotic agents in patients with heart failure remains controversial due to a lack of definitive prospective studies, despite theoretical benefits.
Michael Ezekowitz (1998) conducted an editorial in Heart failure or reduced ventricular function. Antithrombotic agents was evaluated. Antithrombotic agents for patients with heart failure or reduced ventricular function lack definitive prospective studies to conclusively demonstrate their efficacy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: